Sugi Predict

Sugi Predict / Compounds / SCHEMBL693857

SCHEMBL693857

SCHEMBL693857

N#Cc1cccc(-c2cc[c]cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CLK4 Q9HAZ1 1/20 0.53
▸ MAOB P27338 1/20 0.50
▸ PTPN5 P54829 1/20 0.47
▸ GABRG2 P18507 3/20 0.47
▸ GABRB3 P28472 3/20 0.47
▸ GABRA5 P31644 3/20 0.47
▸ GABRA3 P34903 3/20 0.47
▸ XDH P47989 1/20 0.47
▸ SLC22A12 Q96S37 1/20 0.47
▸ GABRA1 P14867 1/20 0.47
▸ IDO1 P14902 2/20 0.46
▸ NOTUM Q6P988 1/20 0.46
▸ PGR P06401 3/20 0.45
▸ MAP4K4 O95819 1/20 0.44
▸ ADRA2C P18825 1/20 0.44
▸ CHEK1 O14757 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27787243 0.89 CLK4 (0.63) CLK4MAOBPTPN5GABRG2GABRB3
Hydrochloric Acid SCHEMBL28007259 0.87 CLK4 (0.61) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL2154026 0.87 CLK4 (0.65) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL270874 0.85 GABRG2 (0.61) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL29425207 0.85 GABRG2 (0.61) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL18411368 0.83 GABRG2 (0.59) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL21189130 0.83 CLK4 (0.57) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL18411383 0.83 GABRG2 (0.59) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL29043202 0.81 CLK4 (0.47) CLK4MAOBPTPN5GABRG2GABRB3
SCHEMBL16779413 0.81 CLK4 (0.47) CLK4MAOBPTPN5GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111094223-B binaphthyl compounds 罗伊特化学仪器制造公司 2023-10-27 — — CN claimed
CN-111094223-A Binaphthyl compounds 罗伊特化学仪器制造公司 2020-05-01 — — CN claimed
US-10076517-B2 Methods and pharmaceutical compositions for the treatment of fibrosis INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE KA RECHERCHE MÉDICALE (FR) 2018-09-18 — — US claimed
EP-2970307-A1 PYRAZOLO COMPOUNDS AND USES THEREOF Genentech, Inc. (US) 2016-01-20 — — EP claimed
CN-102459167-B Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV 2015-04-01 — — CN claimed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO claimed
EP-2421825-B9 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-20 — — EP claimed
US-8691805-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2014-04-08 — — US claimed
EP-2421825-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-01-01 — — EP claimed
US-20130244997-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (US) 2013-09-19 — — US claimed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 — — EP claimed
US-20100331300-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-12-30 — — US claimed
US-20100324014-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-12-23 — — US claimed
WO-2010124119-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 — — WO claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 — — WO claimed
US-20100137297-A1 SPIROINDALONES MERCK SHARP & DOHME LLC 2010-06-03 — — US claimed
CN-101678011-A Spiro-indolinone compounds MERCK & CO INC 2010-03-24 — — CN claimed
EP-2160187-A1 SPIROINDALONES Merck Sharp & Dohme Corp. (US) 2010-03-10 — — EP claimed
WO-2008144266-A1 SPIROINDALONES MERCK & CO., INC. (US) 2008-11-27 — — WO claimed
US-6090841-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS MERCK & CO., INC. (US) 2000-07-18 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10076517-B2 Methods and pharmaceutical compositions for the treatment of fibrosis LIPA, MGLL, PNLIP CLK4 1761/4885MAOB 437/4885PTPN5 1390/4885
US-20130244997-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA CLK4 3615/4885MAOB 428/4885PTPN5 1484/4885
US-20100137297-A1 SPIROINDALONES HIF1AN, HIF1A, EGLN2 CLK4 1441/4885MAOB 3786/4885PTPN5 2851/4885
US-20100331300-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA CLK4 3615/4885MAOB 428/4885PTPN5 1484/4885
US-20100324014-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA CLK4 3615/4885MAOB 428/4885PTPN5 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.